Skip to content
AnalystLens
Back to VTRSIncome Statement

Viatris Net Income 2018-2026 | VTRS

Annual FY2018–FY2025 · quarterly through Q2 FY2026

Latest annual · FY2025

−$3.51B

−454.2%YoY vs FY2024Source: 10-KFY2025

From $352.5M in FY2018 to −$3.51B in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$176M+105.8%−$119M−2482.6%Not reportedNot reported
FY25−$3.0B−2770.8%−$5M+98.6%−$128M−235.2%−$340M+34.2%
FY24$114M−49.3%−$326M−223.6%$95M−71.4%−$517M+32.5%
FY23$225M−43.7%$264M−15.9%$332M−6.4%−$766M−175.7%
FY22$399M+138.5%$314M+212.4%$354M+13.7%$1.0B+483.3%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

N/A

FY2020
−$669.9M
FY2025
−$3.51B

5 years selected · on the chart

Net Income History

Year-over-year comparison from 10-K annual reports

  1. −$3.51B
YoY changeLargest recent move−97.4%in FY23Latest −454.2%

4 older moves run past ±150% (largest −4087.5%); point at, tap or drag across the bars to read one.

Net Income, period by period

PeriodValueChangeSource
FY2025−$3.51B−454.2%10-K
FY2024−$634.2M−1259.4%10-K
FY2023$54.7M−97.4%10-K
FY2022$2.08B+263.8%10-K
FY2021−$1.27B−89.4%10-K
FY2020−$669.9M−4087.5%10-K
FY2019$16.8M−95.2%10-K
FY2018$352.5M—10-K

What is net income?

Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.

What is Viatris's current net income?

Viatris (VTRS) annual net income for 2025 was $-3.51B, a 454.23% decline from 2024. Viatris net income for the quarter ending June 30, 2026 was $-118.8M.

What was Viatris's net income in 2024?

Viatris annual net income for 2024 was $-634.2M, a 1259.41% decline from 2023.

What was Viatris's net income in 2023?

Viatris annual net income for 2023 was $54.7M, a 97.37% decline from 2022.

Company
Viatris
Ticker
VTRS
Sector
Healthcare
Industry
Pharmaceutical Preparations